Report of Adverse Events in Colombia: A Successful Case.
Curr Drug Saf
; 14(1): 53-56, 2019.
Article
de En
| MEDLINE
| ID: mdl-30411692
ABSTRACT
BACKGROUND:
The Colombian National Food and Drug Surveillance Institute (INVIMA) is responsible for monitoring the safety and efficacy of medicines circulating the Colombian market.DISCUSSION:
This article summarizes the three key strategies the institution has implemented to strengthen the National Pharmacovigilance Program improving the interaction and working relationship with regional health authorities, expanding the National Pharmacovigilance Network and implementing the electronic submission of adverse events.CONCLUSION:
The number of adverse events reported in Colombia increased from 5,447 in 2013 to 95,658 in 2017, reaching a population-based reporting ratio within international standards (563 in 2016).Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Systèmes de signalement des effets indésirables des médicaments
/
Effets secondaires indésirables des médicaments
/
Pharmacovigilance
Type d'étude:
Diagnostic_studies
Limites:
Humans
Pays/Région comme sujet:
America do sul
/
Colombia
Langue:
En
Journal:
Curr Drug Saf
Année:
2019
Type de document:
Article
Pays d'affiliation:
Colombie